What does Boehringer Ingelheims policy paper tell us about the corporations commitment in the fight against HIV/AIDS in Emerging Economies?
Policy Paper Preface The HIV/AIDS pandemic is destroying lives and deteriorating living conditions all over the globe; 95% of people living with HIV/AIDS are in the developing world with limited access to life saving anti-retroviral drugs. At the end of 2006 more than 75% of patients in need of drugs in sub-Saharan Africa did not receive adequate treatment. In addition, only 10% of children born to HIV positive mothers benefit from interventions to prevent the mother-to-child transmission.